Company facts
- Industry
- Services-Medical Laboratories
- Headquarters
- Sunnyvale, California
- Most recent report
- 10-Q, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 254 filings
- On EDGAR
- CIK 1699031
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Emerging growth company
Financials 8 of 9
News 8 of 27
Prospectuses and Registrations 8 of 9
- S-8 Registration statement for an employee plan Mar 12, 2026
- 424B5 Prospectus supplement for an offering Nov 14, 2025
- S-3ASR Automatic shelf registration Nov 13, 2025
- S-8 Registration statement for an employee plan May 14, 2025
- S-8 Registration statement for an employee plan Mar 5, 2025
- S-8 Registration statement for an employee plan Aug 30, 2024
- S-8 Registration statement for an employee plan Jun 21, 2024
- S-1/A Registration statement for an offering, amended Sep 17, 2020
Proxies 5
Ownership 8 of 171
- 4 Insider reported a trade Sep 23, 2026
- 4 Insider reported a trade Sep 23, 2026
- 144 Notice of a proposed sale of restricted stock Sep 21, 2026
- 4 Insider reported a trade Aug 31, 2026
- 4 Insider reported a trade Aug 31, 2026
- 144 Notice of a proposed sale of restricted stock Aug 27, 2026
- 144 Notice of a proposed sale of restricted stock Aug 27, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
Other 8 of 33
Everything here comes from GRAIL, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.